The MicroArray Quality Control consortium—a 16-year international effort led by the FDA and involving hundreds of scientists from academia, industry and government—helped make genomic medicine a reality.
This is a preview of subscription content
Subscription info for Chinese customers
We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Tan, P. K. et al. Nucleic Acids Res. 31, 5676–5684 (2003).
Taylor, J. K. Anal. Chem. 55, 600A–608A (1983).
Zook, J. M. et al. Nat. Biotechnol. 37, 561–566 (2019).
Critical Path Institute. Patient-Reported Outcome Consortium https://c-path.org/programs/proc/ (accessed 1 August 2021).
Quantitative Imaging Biomarkers Alliance. https://www.rsna.org/research/quantitative-imaging-biomarkers-alliance (accessed 2 August 2021).
The authors declare no competing interests.
About this article
Cite this article
Salit, M., Woodcock, J. MAQC and the era of genomic medicine. Nat Biotechnol 39, 1066–1067 (2021). https://doi.org/10.1038/s41587-021-01050-y